Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Pre vs post operative initiation of Thromboprophylaxis in Liver surgeries

Pre vs post operative initiation of Thromboprophylaxis in Liver surgeries

GAPS trial: Low-dose LMWH and GCS in in elective surgical inpatients at moderate or high risk VTE

GAPS trial: Low-dose LMWH and GCS in in elective surgical inpatients at moderate or high risk VTE

ASH 2019 Guidelines for Surgical Prophylaxis

ASH 2019 Guidelines for Surgical Prophylaxis

Single injectable treatment may not be enough to get T2DM patient to Glycemic goal

Single injectable treatment may not be enough to get T2DM patient to Glycemic goal

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

VTE Prophylaxis in Surgical Patients

VTE Prophylaxis in Surgical Patients

Acute Medical Illness: Advanced Age Alone Predicts Venous Thromboembolism Similar to Existing Risk Assessment Models

Acute Medical Illness: Advanced Age Alone Predicts Venous Thromboembolism Similar to Existing Risk Assessment Models

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

VTE Risk Assessment in Surgical Patients

VTE Risk Assessment in Surgical Patients

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Identifying and Treating Patients with High Lipidaemia Risk Post-ACS

Identifying and Treating Patients with High Lipidaemia Risk Post-ACS